Pliant Therapeutics Inc (PLRX) — Financial Flexibility Index
Pliant Therapeutics Inc (PLRX) has a Financial Flexibility Index of -0.28x as of September 2025. Free cash flow of $-21.08 Million (operating CF $-21.08 Million minus capex $0.00) represents 0% of total liabilities ($76.29 Million). Also explore Pliant Therapeutics Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pliant Therapeutics Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Pliant Therapeutics Inc across 8 annual periods. Check Pliant Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Pliant Therapeutics Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Pliant Therapeutics Inc. For the full company profile including market capitalisation, see Pliant Therapeutics Inc (PLRX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.63x | $-151.66 Million | $-155.50 Million | $92.87 Million | ▲ +45.4% |
| 2023 | -2.99x | $-115.44 Million | $-116.36 Million | $38.58 Million | ▼ -20.1% |
| 2022 | -2.49x | $-92.87 Million | $-94.63 Million | $37.27 Million | ▲ +24.9% |
| 2021 | -3.32x | $-73.49 Million | $-75.44 Million | $22.16 Million | ▼ -15.7% |
| 2020 | -2.87x | $-35.74 Million | $-37.27 Million | $12.46 Million | ▼ -19083.7% |
| 2019 | -0.01x | $-1.79 Million | $-2.75 Million | $119.50 Million | ▲ +96.1% |
| 2018 | -0.39x | $-26.00 Million | $-28.33 Million | $67.41 Million | ▲ +92.1% |
| 2017 | -4.87x | $-15.52 Million | $-16.92 Million | $3.19 Million | — |